Hepatic triglyceride lipase promotes low density lipoprotein receptor- mediated catabolism of very low density lipoproteins in vitro

Journal of Lipid Research

Volumn 40, Issue 7, 1999, Pages 1263-1275

  Medh, Jheem D ^a   Bowen, Susan L ^a   Fry, Glenna L ^a   Ruben, Stacie ^a   Hill, John ^b,c   Wong, Howard ^b,c   Chappell, David A ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

Heparan sulfate proteoglycans; Hepatic lipase; LDL receptor; LDL receptor related protein; Lipoprotein lipase

Indexed keywords

HEPARIN LYASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CATABOLISM; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; SKIN FIBROBLAST;

ALPHA-MACROGLOBULINS; ANIMALS; CELL LINE; FIBROBLASTS; HEPARIN LYASE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LIPASE; LIPOPROTEINS, VLDL; LIVER; MICE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL;

EID: 0032809677     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Olivecrona, T., and G. Bengtsson-Olivecrona. 1993. Lipoprotein lipase and hepatic lipase. Curr. Opin. Lipidol. 4: 187-196.
2. Jansen, H., and W. C. Hulsmann. 1985. Enzymology and physiological role of hepatic lipase. Biochem. Soc. Trans. 13: 24-26.
3. Bensadoun, A., and D. E. Berryman. 1996. Genetics and molecular biology of hepatic lipase. Curr. Opin. Lipidol. 7: 77-81.
4. Beisiegel, U. 1996. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis [Review]. Atherosclerosis. 124: 1-8.
5. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6: 291-305.
6. Sultan, F., D. Lagrange, H. Jansen, and S. Griglio. 1990. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim. Biophys. Acta. 1042: 150-152.
7. Goldberg, I. J., N. A. Le, J. R. Paterniti, Jr., H. N. Ginsberg, F. T. Lindgren, and W. V. Brown. 1982. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J. Clin. Invest. 70: 1184-1192.
8. Shafi, S., S. E. Brady, A. Bensadoun, and R. J. Havel. 1994. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35: 709-720.
9. Jansen, H., A. van Tol, and W. C. Hulsmann. 1980. On the metabolic function of heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 92: 53-59.
10. Murase, T., and H. Itakura. 1981. Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis. 39: 293-300.
11. Connelly, P. W., G. F. Maguire, M. Lee, and J. A. Little. 1990. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 10: 40-48.
12. Hegele, R. A., J. A. Little, C. Vezina, G. F. Maguire, L. Tu, T. S. Wolever, D. J. A. Jenkins, and P. W. Connelly. 1993. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
13. Breckenridge, W. C., J. A. Little, P. Alaupovic, C. S. Wang, A. Kuksis, G. Kakis, F. Lindgren, and G. Gardiner. 1982. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 45: 161-179.
14. Dugi, K. A., L. M. Feuerstein, S. Hill, J. Shih, S. Santamarina-Fojo, H. B. Brewer, and J. M. Hoeg. 1997. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17: 354-364.
15. Busch, S. J., R. L. Barnhart, G. A. Martin, M. C. Fitzgerald, M. T. Yates, S. J. Mao, C. E. Thomas, and R. L. Jackson. 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269: 16376-16382.
16. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
17. Applebaum-Bowden, D., J. Kobayashi, V. S. Kashyap, D. R. Brown, A. Berard, S. Meyn, C. Parrott, N. Maeda, R. Shamburek, H. B. Brewer, and S. Santamarina-Fojo. 1996. Hepatic lipase gene therapy in hepatic lipase-deficient mice - adenovirus-mediated replacement Of a lipolytic enzyme to the vascular endothelium. J. Clin. Invest. 97: 799-805.
18. Diard, P., M. I. Malewiak, D. Lagrange, and S. Griglio. 1994. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299: 889-894.
19. Krapp, A., S. Ahle, S. Kersting, Y. Hua, K. Kneser, M. Nielsen, J. Gliemann, and U. Beisiegel. 1996, Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37: 926-936.
20. Sultan, F., D. Lagrange, X. Le Liepvre, and S. Griglio. 1989. Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase. Biochem. J. 258: 587-594.
21. Kounnas, M. Z., D. A. Chappell, H. Wong, W. S. Argraves, and D. K. Strickland. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270: 9307-9312.
22. Ji, Z. S., S. J. Lauer, S. Fazio, A. Bensadoun, J. M. Taylor, and R. W. Mahley. 1994. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269: 13429-13436.
23. Medh, J. D., S. L. Bowen, G. L. Fry, S. Ruben, M. Andracki, I. Inoue, J. M. Lalouel, D. K. Strickland, and D. A. Chappell. 1996. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J. Biol. Chem. 271: 17073-17080.
24. Chappell, D. A. 1988. Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia). J. Clin. Invest. 82: 628-639.
25. Iverius, P. H., and A. M. Ostlund-Lindqvist. 1976. Lipoprotein lipase from bovine milk. Isolation procedure, chemical characterization, and molecular weight analysis. J. Biol. Chem. 251: 7791-7795.
26. Hill, J. S., R. C. Davis, D. Yang, J. Wen, J. S. Philo, P. H. Poon, M. L. Phillips, E. S. Kempner, and H. Wong. 1996. Human hepatic lipase subunit structure determination. J. Biol. Chem. 271: 22931-22936.
27. Williams, S. E., J. D. Ashcom, W. S. Argraves, and D. K. Strickland. 1992. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J. Biol. Chem. 267: 9035-9040.
28. Chappell, D. A., I. Inoue, G. L. Fry, M. W. Pladet, P. H. Iverius, J. M. Lalouel, and D. K. Strickland. 1994. The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Ann. NY Acad. Sci. 737: 434-438.
29. Williams, S. E., I. Inoue, H. Tran, G. L. Fry, M. W. Pladet, P. H. Iverius, J. M. Lalouel, D. A. Chappell, and D. K. Strickland. 1994. The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J. Biol. Chem. 269: 8653-8658.
30. Chappell, D. A., I. Inoue, G. L. Fry, M. W. Pladet, S. L. Bowen, P. H. Iverius, J. M. Lalouel, and D. K. Strickland. 1994. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J. Biol. Chem. 269: 18001-18006.
31. Bilheimer, D. W., S. Eisenberg, and R. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
32. McGowan, M. W., J. D. Artiss, D. R. Strandbergh, and B. C. Zak. 1983. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29: 538-542.
33. Rumsey, S. C., J. C. Obunike, Y. Arad, R. J. Deckelbaum, and I. J. Goldberg. 1992. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 90: 1504-1512.
34. Hamilton-Attwell, V. L., J. Du Plessis, and C. J. Van Wyk. 1986. A new scanning electron microscope (SEM) method for the determination of particle size in parenteral fat emulsions. J. Microsc. 145: 347-349.
35. Chappell, D. A., G. L. Fry, M. A. Waknitz, and J. J. Berns. 1992. Evidence for isomerization during binding of apolipoproteinB-100 to low density lipoprotein receptors. J. Biol. Chem. 267: 270-279.
36. Chappell, D. A., G. L. Fry, M. A. Waknitz, and J. J. Berns. 1991. Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding. J. Biol. Chem. 266: 19296-19302.
37. Hobbs, H. H., M. S. Brown, D. W. Russell, J. Davignon, and J. L. Goldstein. 1987. Deletion in the gene for the low-density lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N. Engl. J. Med. 317: 734-737.
38. Willnow, T. E., and J. Herz. 1994. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J. Cell Sci. 107: 719-726.
39. Brown, M. S., J. R. Faust, J. L. Goldstein, I. Kaneko, and A. Endo. 1978. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J. Biol. Chem. 253: 1121-1128.
40. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
41. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-276.
42. Van Driel, I. R., M. S. Brown, and J. L. Goldstein. 1989. Stoichiometric binding of low density lipoprotein (LDL) and monoclonal antibodies to LDL receptors in a solid phase assay. J. Biol. Chem. 264: 9533-9538.
43. Medh, J. D., G. L. Fry, S. L. Bowen, M. W. Pladet, D. K. Strickland, and D. A. Chappell. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270: 536-540.
44. Beisiegel, U., A. Krapp, W. Weber, and G. Olivecrona. 1994. The role of alpha 2M receptor/LRP in chylomicron remnant metabolism. Ann. NY Acad. Sci. 737: 53-69.
45. Nykjaer, A., G. Bengtsson-Olivecrona, A. Lookene, S. K. Moestrup, C. M. Petersen, W. Weber, U. Beisiegel, and J. Gliemann. 1993. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 268: 15048-15055.
46. Kutt, H., J. Herz, and K. K. Stanley. 1989. Structure of the low-density lipoprotein receptor-related protein (LRP) promoter. Biochim. Biophys. Acta. 1009: 229-236.
47. Chappell, D. A., G. L. Fry, M. A. Waknitz, L. E. Muhonen, and M. W. Pladet. 1993. Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro. J. Biol. Chem. 268: 25487-25493.
48. Orlando, R. A., and M. G. Farquhar. 1994. Functional domains of the receptor-associated protein (RAP). Proc. Natl. Acad. Sci. USA. 91: 3161-3165.
49. Busch, S. J., J. L. Krstenansky, T. J. Owen, and R. L. Jackson. 1989. Human hepatoma (HepG2) cells secrete a single 65 K dalton triglyceride lipase immunologically identical to postheparin plasma hepatic lipase. Life Sci. 45: 615-622.
50. Lombardi, P., M. Mulder, E. de Wit, T. J. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low-density lipoproteins are degraded in HepG2 cells with low efficiency. Biochem. J. 290: 509-514.
51. Ji, Z. S., S. Fazio, and R. W. Mahley. 1994. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J. Biol. Chem. 269: 13421-13428.
52. Mulder, M., P. Lombardi, H. Jansen, T. J. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268: 9369-9375.
53. Laposata, E. A., H. M. Laboda, J. M. Glick, and J. F. Strauss. 1987. Hepatic lipase. Synthesis, processing, and secretion by isolated rat hepatocytes. J. Biol. Chem. 262: 5333-5338.
54. Komaromy, M., S. Azhar, and A. D. Cooper. 1996. Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester. J. Biol. Chem. 271: 16906-16914.
55. Choi, S. Y., M. C. Komaromy, J. Chen, L. G. Fong, and A. D. Cooper. 1994. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J. Lipid Res. 35: 848-859.
56. Aviram, M., E. L. Bierman, and A. Chait. 1988. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 263: 15416-15422.
57. Chang, S., and J. Borensztajn. 1995. Uptake of chylomicron remnants and hepatic lipase-treated chylomicrons by a non-transformed murine hepatocyte cell line in culture. Biochim. Biophys. Acta. 1256: 81-87.
58. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89: 9252-9256.
59. Strickland, D. K., J. D. Ashcom, S. Williams, F. Battey, E. Behre, K. McTigue, J. F. Battey, and W. S. Argraves. 1991. Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J. Biol. Chem. 266: 13364-13369.
60. Moestrup, S. K., T. L. Holtet, M. Etzerodt, H. C. Thogersen, A. Nykjaer, P. A. Andreasen, H. H. Rasmussen, L. Sottrup-Jensen, and J. Gliemann. 1993. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J. Biol. Chem. 268: 13691-13696.
61. Salinelli, S., J. Y. Lo, M. P. Mims, E. Zsigmond, L. C. Smith, and L. Chan. 1996. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center. J. Biol. Chem. 271: 21906-21913.
62. Datta, S., C-C. Luo, W-H. Li, P. VanTuinen, D. H. Ledbetter, M. A. Brown, S-H. Chen, S-W. Liu, and L. Chan. 1988. Human hepatic lipase. J. Biol. Chem. 263: 1107-1110.
63. Brasaemle, D. L., K. Cornely-Moss, and A. Bensadoun. 1993. Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J. Lipid Res. 34: 455-465.
64. Lookene, A., N. Skottova, and G. Olivecrona. 1994. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat). Eur. J. Biochem. 222: 395-403.
65. DeFaria, E., L. G. Fong, M. Komaromy, and A. D. Cooper. 1996. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J. Lipid Res. 37: 197-209.
66. Martin, G. A., S. J. Busch, G. D. Meredith, A. D. Cardin, D. T. Blankenship, S. J. T. Mao, A. E. Rechtin, C. W. Woods, M. M. Racke, Schafer, M. P., M. C. Fitzgerald, D. M. Burke, M. A. Flanagan, and R. L. Jackkson. 1988. Isolation and cDNA sequence of human postheparin plasma hepatic triglyceride lipase. J. Biol. Chem. 263: 10907-10914.
67. Staels, B., A. Van Tol, L. Chan, H. Will, G. Verhoeven, and J. Auwerx. 1990. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology. 127: 1144-1152.
68. Hulsmann, W. C., M. C. Oerlemans, and M. M. Geelhoed-Mieras. 1977. Effect of hypothyroidism, diabetes and polyunsaturated fatty acids on heparin-releasable rat liver lipase. Biochem. Biophys. Res. Commun. 79: 784-788.